Patent details

EP2522717 Title: Oligopeptide-free cell culture media.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2522717
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12160789.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
03/01/2007
Grant date:
02/04/2014
EP Publication Date:
02/04/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
02/04/2014
EP B1 Publication Date:
02/04/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
24/06/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/01/2027
Lapsed By Expiration Date:
Revocation Date:
12/07/2022
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/06/2021
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Historical Applicant/holder

From:
05/04/2016
To:
17/06/2021

 

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

From:
05/04/2016
To:
17/06/2021

 

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

From:
02/04/2014
To:
05/04/2016

 

Name:
Baxter International Inc
Address:
One Baxter Parkway, DEERFIELD, IL 60015, United States of America (US)

From:
02/04/2014
To:
05/04/2016

 

Name:
Baxter Healthcare SA
Address:
Thurgauerstrasse 130, 8152 GLATTPARK (OPFIKON), Switzerland (CH)

Domicile Holder

Name:
ir. H.A. Witmans c.s.
From:
02/04/2014
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Grillberger, Leopold
Address:
1220 VIENNA, Austria (AT)

2

Name:
Reiter, Manfred
Address:
1150 VIENNA, Austria (AT)

3

Name:
Mundt, Wolfgang
Address:
1080 VIENNA, Austria (AT)

4

Name:
Mitterer, Artur
Address:
2304 ORTH/DONAU, Austria (AT)

Priority

Priority Patent Number:
756419 P
Priority Date:
04/01/2006
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C12N 5/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
37/22
Publication date:
14/09/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
27/21
Publication date:
07/07/2021
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
22/16
Publication date:
01/06/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
VB1
Journal edition number:
2015/08
Publication date:
18/02/2015
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
EP3
Journal edition number:
2014/27
Publication date:
02/07/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2014/15
Publication date:
09/04/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202237
Publication date:
14/09/2022
Description:
Revocation of the European patent

2

Issue number:
201507
Publication date:
11/02/2015
Description:
Opposition procedure started

3

Issue number:
201414
Publication date:
02/04/2014
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202101203A
Date Registered:
17/06/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201600876B
Date Registered:
05/04/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & Mc.Kenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

2

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
16/12/2021
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
25/05/2016 Outgoing Correspondence Outgoing Letter 1 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_0_58322l118.pdf
05/04/2016 Incoming Correspondence Paper Other 357 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_1_incomingcorrespondencepaper20160525021031381.pdf
05/04/2016 Request for Change Subsequently filed deed 18 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_2_rfc20160525021031294.pdf
05/04/2016 Incoming Correspondence Paper Other 306 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_3_incomingcorrespondencepaper20160601092948490.pdf
05/04/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_6_incomingcorrespondencepaper20160525021031155.pdf
05/04/2016 Incoming Correspondence Paper Other 3 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_8_incomingcorrespondencepaper20160525021031239.pdf
25/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_9_outgoingcorrespondence20140625.pdf
24/06/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_4_incomingcorrespondencepaper20140624.pdf
24/06/2014 Claims Translated claims 2 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_5_claims20140624.pdf
24/06/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_7_incomingcorrespondencepaper20140624.pdf
24/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /9/8/7/0/6/0512160789/docs/ep12160789.9_10_outgoingcorrespondence20140624.pdf